This content is from: Premium Nuvation Bio Flounders After EcoR1 SPAC Merger In just five days the shares of the biopharma company that merged with Oleg Nodelman’s blank check company fell by more than one-third. By Stephen Taub March 31, 2021
This content is from: Premium Another Newly Merged SPAC Is Getting Mauled. Here’s Why Hedge Fund Investors Aren’t Worried. Cano Health, backed by Suvretta, Third Point, and others, has been on the decline since merging with Jaws Acquisition in early June. By Stephen Taub June 30, 2021
This content is from: Premium Two Hedge Funds Poised to Benefit From a SPAC Deal Worth $1.6 Billion Sarissa and Perceptive stands to benefit from Pear Therapeutics’ merger with Pritzker-backed blank check company. By Stephen Taub June 22, 2021
This content is from: RIAIntel The Pandemic’s Permanent Mark on Wealth Management M&A Buying and selling advisory businesses will never be the same, according to a new report. By Michael Thrasher May 10, 2021
This content is from: Corner Office Ultra-Low Interest Rates Are Driving Insurers Into the Arms of Private Equity Cerulli Associates expects to see more private equity mergers and acquisitions in the insurance industry as a result of the pandemic. By Amy Whyte September 17, 2020
This content is from: RIAIntel The M&A Dots Wealth Managers Are Failing to Connect Nearly half of RIAs want to acquire or merge with another RIA in the next 24 months. Most are not going to do that, according to a report by Dimensional Fund Advisors. By Michael Thrasher May 20, 2021
